Irritable Bowel Syndrome (IBS-C)
3 clinical trials · Condition
◉ Watch Irritable Bowel Syndrome (IBS-C)
| Record | Firm | Date |
|---|---|---|
| The Effect of Tegaserod on Patterns of Flow in the Small Bowel of Patients With Irritable Bowel Syndrome (IBS) (NCT00171431) | Novartis Pharmaceuticals | 2004-11-01 |
Track Irritable Bowel Syndrome (IBS-C) automatically
Every clearance here is in the API, with alerts when new ones post.